Atossa Therapeutics, Inc.ATOSNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-21.05M
↓ 56% below average
Average (9y)
$-13.51M
Historical baseline
Range
High:$-5.38M
Low:$-21.05M
CAGR
+4.6%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-21.05M | -0.4% |
| 2023 | $-20.95M | -0.8% |
| 2022 | $-20.79M | -26.1% |
| 2021 | $-16.48M | -42.3% |
| 2020 | $-11.58M | -26.7% |
| 2019 | $-9.14M | -0.7% |
| 2018 | $-9.07M | -37.6% |
| 2017 | $-6.59M | -22.5% |
| 2016 | $-5.38M | +61.8% |
| 2015 | $-14.08M | - |